Ovid Therapeutics Inc.
OVID· Nasdaq
Released Nov 8, 2018, before the open
10-Q filed Nov 8, 2018, 39 days after period end · 0001564590-18-028299
| Metric | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|
| Net Income | -$12.96M | -$9.36M | -$5.79M |
| EPS Diluted | -$0.53 | -$0.38 | -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2018 · filed Nov 8, 2018 · 39 d after period end
+2.2% from the close of Nov 6, 2018 to the close of Nov 8, 2018, the first after the release.